Nalaganje...
Protein Kinase Cα Mediates Erlotinib Resistance in Lung Cancer Cells
Overexpression and mutational activation of the epidermal growth factor receptor (EGFR) plays an important role in the pathogenesis of non–small cell lung cancer (NSCLC). EGFR tyrosine-kinase inhibitors (TKIs) are given as a primary therapy for advanced patients with EGFR-activating mutations; howev...
Shranjeno v:
| izdano v: | Mol Pharmacol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
The American Society for Pharmacology and Experimental Therapeutics
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4407729/ https://ncbi.nlm.nih.gov/pubmed/25724832 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/mol.115.097725 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|